Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: Different profiles according to low-density lipoprotein cholesterol

被引:18
|
作者
Kim, Suk Jae [1 ]
Park, Yun Gyoung [2 ]
Kim, Ji Hyun [2 ]
Han, Yun Kyung [2 ]
Cho, Hong Keun [3 ]
Bang, Oh Young [1 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea
[3] Dr Chos Internal Med Clin, Seoul, South Korea
关键词
Triglycerides; Cholesterol; Atherosclerotic stroke; Apolipoprotein A5; TRANSIENT ISCHEMIC ATTACK; HEALTH-CARE PROFESSIONALS; CARDIOVASCULAR-DISEASE; HEART-DISEASE; APOA5; GENE; RISK; ASSOCIATION; PREVENTION; ATORVASTATIN; GUIDELINES;
D O I
10.1016/j.atherosclerosis.2012.05.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although low-density lipoprotein cholesterol (LDL-C) is the main lipid target for cardiovascular risk reduction, recent studies suggest that other lipid indicies are also associated with vascular events. We hypothesized that the association of triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) with atherosclerotic stroke (AS) differs depending on LDL-C levels. Data prospectively collected on subjects admitted with acute ischemic stroke to a university medical center were analyzed. We divided the patients into AS and non-atherosclerotic stroke (NAS) groups and independent association of lipid parameters and genetic influences of apolipoprotein A5 (ApoA5) polymorphisms with AS were evaluated. Of 268 patients, 160 (59.7%) were classified with AS and 108 (40.3%) were classified with NAS. Vascular risk factors were more prevalent in AS patients than in those with NAS; additionally, AS patients' anthropometric indexes and laboratory findings showed that they were prone to atherosclerosis. AS was independently associated with fasting TG (OR per 10 mg/dL increase, 1.38; 95% CI, 1.16-1.64; OR for highest vs. lowest tertile, 12.85; 95% CI, 3.31-49.85), HDL-C (OR per 10 mg/dL increase, 0.61; 95% CI, 0.42-0.88; OR for lowest vs. highest tertile, 4.28; 95% CI, 1.16-15.86), and nonfasting TG (OR per 10 10 mg/dL increase, 1.25; 95% CI, 1.11-1.42; OR for highest vs. lowest tertile, 8.20; 95% CI, 1.98-33.88) only among patients with LDL <100 mg/dL. No interaction was observed between fasting and nonfasting TG and ApoA5 polymorphisms. In conclusion, fasting and nonfasting TG and HDL-C were associated with AS only when patients had low levels of LDL-C. Non-LDL-C may have an additional role in addition to the LDL-C levels in AS development. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:463 / 467
页数:5
相关论文
共 50 条
  • [41] Raising high-density lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization
    Bates, ER
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12A): : 28L - 34L
  • [42] WEIGHT-REDUCTION RAISES HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA
    DAVIS, TA
    ANDERSON, EC
    VARHOL, A
    GOLDBERG, AP
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1982, 35 (04): : 823 - 823
  • [43] WEIGHT-REDUCTION RAISES HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA
    DAVIS, TA
    ANDERSON, EC
    VARHOL, A
    GOLDBERG, AP
    CLINICAL RESEARCH, 1982, 30 (02): : A620 - A620
  • [44] Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol
    Kawano, Yoshiyuki
    Tamura, Akira
    Kadota, Junichi
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (02): : 186 - 192
  • [45] Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer
    Qingqing Lin
    Wenchao Liu
    Song Xu
    Liping Sun
    Archives of Gynecology and Obstetrics, 2022, 305 : 683 - 691
  • [46] Predictive Value of the Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio for the Prevention of Stroke Recurrence in Japanese Patients Treated with Rosuvastatin
    Michiya Igase
    Katsuhiko Kohara
    Ryosuke Katagi
    Shiro Yamashita
    Mutsuo Fujisawa
    Tetsuro Miki
    Clinical Drug Investigation, 2012, 32 : 513 - 521
  • [47] Predictive Value of the Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio for the Prevention of Stroke Recurrence in Japanese Patients Treated with Rosuvastatin
    Igase, Michiya
    Kohara, Katsuhiko
    Katagi, Ryosuke
    Yamashita, Shiro
    Fujisawa, Mutsuo
    Miki, Tetsuro
    CLINICAL DRUG INVESTIGATION, 2012, 32 (08) : 513 - 521
  • [48] Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
    Katsiki, Niki
    Vrablik, Michal
    Banach, Maciej
    Gouni-Berthold, Ioanna
    PHARMACEUTICALS, 2023, 16 (04)
  • [49] EFFECT OF LOW-DOSE NIACIN ON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND TOTAL CHOLESTEROL HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO
    LURIA, MH
    ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (11) : 2493 - 2495
  • [50] Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses
    Jia, Lianqun
    Long, Shiyin
    Fu, Mingde
    Yan, Bingyu
    Tian, Ying
    Xu, Yanhua
    Gou, Lantu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (09): : 1141 - 1148